According to Yucca Health's safety information pages, GLP-1 medications like semaglutide and tirzepatide have important contraindications: Do not use if: You or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You have had a severe allergic reaction to semaglutide, tirzepatide, or any ingredients in the formulation You are pregnant, planning to become pregnant, or breastfeeding (GLP-1 medications are not recommended during pregnancy or breastfeeding) Use with caution and close medical supervision if you have: History of pancreatitis or pancreas problems Kidney problems or history of kidney disease Severe gastrointestinal issues such as gastroparesis Type 2 diabetes with history of diabetic retinopathy (semaglutide specifically) Are taking other medications including insulin or sulfonylureas (increased risk of hypoglycemia) The provider reviewing your intake will screen for these factors and may decline to prescribe if contraindications are present or request additional information before making a determination
Fully oxidized (AT-2-treated), fully reduced (DTT-treated) and untreated cells, that were not pre-reduced were used to calibrate roGFP2
Pharmacy compounding of human drug products under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance
Wamala R, Kizito OS, Jjemba E
Gayoso-Diz P, Otero-Gonzlez A, Rodriguez-Alvarez MX, et al
